RFB002

BIOLOGICAL2 trials

Sponsors

Novartis Pharmaceuticals

Conditions

Diabetic Macular EdemaRetinal Vein OcclusionVisual Impairment

Phase 2

Efficacy and Safety of Ranibizumab (Intravitreal Injections) Versus Laser Treatment in Patients With Visual Impairment Due to Diabetic Macular Edema

CompletedNCT00901186

Novartis PharmaceuticalsDiabetic Macular Edema, Visual Impairment

Start: 2009-11-30End: 2012-08-31Updated: 2017-03-03

Phase 4

Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVO

CompletedNCT01580020

Novartis PharmaceuticalsRetinal Vein Occlusion

Start: 2012-05-31End: 2014-10-31Updated: 2016-05-17